Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 30.10.2026 GNOV LN IE000OJ31JQ4 800,002.00 USD 30,361,411.29 37.952 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 30.10.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,433,940.61 28.678 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 30.10.2026 FTEG.LN IE0009F7UB30 125,002.00 EUR 2,705,820.09 21.646 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 30.10.2026 FJAN.LN IE000MDKBOB3 150,002.00 USD 4,432,833.54 29.552 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 30.10.2026 FPX. IE00BYTH6238 225,002.00 USD 14,186,029.56 63.048 ...
-
Arrowhead Pharmaceuticals to Present Important Clinical Data at the American Heart Association Scientific Sessions 2026
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it will present important data at this week’s American Heart Association Scientific Sessions in Chicago. AHA 2026 Oral Presentations Date & Time: Saturday, November 7, 3:15 – 4:30 pm CT Session Title: FS.05: Featured Science Session on Novel Lipid Lowering Therapies Location: Learning Studio 2‚ Science and Technology Hall‚ South Hall Title: First-in-Human Trial of a Dual Functional RNAi Mo...
-
Siva Barnwell Adams Named Corporate Secretary and Chief Governance Officer
HOUSTON--(BUSINESS WIRE)--Chevron Corporation (NYSE: CVX) has named Siva Barnwell Adams corporate secretary and chief governance officer, effective Jan. 1, 2027.In her new role, Barnwell Adams will counsel the board of directors and Chevron’s senior management on corporate governance matters, manage the Corporate Governance Department and serve on the Law Function Executive Committee. She succeeds Mary A. Francis, who will retire from Chevron in May 2027 after 25 years with the company.“Siva bri...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 30.10.2026 GAUG LN IE000TGSG3Y5 900,002.00 USD 33,886,121.32 37.651 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 30.10.2026 MSEP.LN IE0009DRFET8 50,002.00 USD 1,422,744.24 28.454 ...
-
Verastem Oncology to Participate in Upcoming November Investor Conferences
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to present at the following investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference in Boston: November 9, 4:00-4:25pm ET Wolfe Research Healthcare Conference in New York City: November 10, 4:00-4:30pm ET Jefferies London Healthcare Conference in Lo...